Clinical Trials Browser

Interventional × Urinary Bladder Neoplasms × Surgical Procedures, Operative × Clear all

NCT04700124 2026-02-05

KEYNOTE-B15

Phase 3 Completed

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

NCT03978624 2025-10-15

Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer

Phase 2 Active not recruiting

20 enrolled 11 charts

Urinary Bladder Neoplasms

NCT06427824 2025-10-03

Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy

Phase NA Recruiting

Urinary Bladder Neoplasms

NCT03924856 2025-08-28

KEYNOTE-866

Phase 3 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

NCT00938145 2025-04-11

3 Tesla MRI in Patients With Bladder Cancer

Phase NA Active not recruiting

Urinary Bladder Neoplasms

NCT04588168 2020-10-19

Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial Carcinoma

Phase NA Recruiting

Urinary Bladder Neoplasms

NCT00045630 2013-05-27

S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium

Phase 2 Completed

77 enrolled 11 charts

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00003824 2012-03-09

S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer

Phase 3 Terminated

Urinary Bladder Neoplasms

NCT00003640 2012-03-06

Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer

Phase 2 Terminated

Urinary Bladder Neoplasms